Aurelle Health launches in India with a focus on women’s hormonal wellness

Paridhi Maheshwari, the Founder of Aurelle Health
WT default author logo
Women's Tabloid News Desk

Aurelle Health, a direct-to-consumer (D2C) nutraceutical brand with a focus on women’s hormonal health, has officially made its debut in India. Drawing its roots from Balaxi Pharmaceuticals, the brand’s launch is grounded in the concerning statistic that one in five Indian women suffers from hormonal disorders such as Polycystic Ovary Syndrome (PCOS). Aurelle Health is committed not only to offering solutions but also to raising awareness about the importance of hormone health among women.

The brand’s initial product lineup spans four key categories: hair health, skin health, gut health, and weight management. Among the newly introduced products are Clear Canvas, Mane and Maintain, Gut Health, and Tone it Down. Each product boasts being non-GMO, clinically validated, sugar-free, and vegan, catering to the needs of health-conscious consumers.

Paridhi Maheshwari, the Founder of Aurelle Health, shares that her own experience with PCOS and her background in the pharmaceutical sector have heavily influenced the brand’s development. Currently, Aurelle Health’s products are available on their official website, Amazon, and in selected skin and hair clinics. Plans are underway to expand their availability across major e-commerce platforms and clinic chains in key Indian cities.

“Hormonal imbalances are caused due to unhealthy eating, sedentary lifestyles and genetic factors and there is no real cure to PCOS or symptoms caused by hormonal imbalances -it just have to be through diet, lifestyle and supplements. The type and severity are varying and vast and there is no ‘one size fits all’ solution. Hence, Aurelle Health incorporates the goodness of natural ingredients, backed with scientific research, to ease everyday life of modern Indian women. We aim to touch the lives of women across the country through both our products and the community we are building,” Maheshwari stated, highlighting how her personal journey with PCOS played a pivotal role in the brand’s creation.

Share:

Related Insights

Liverpool Health Partners appoints Professor Louise Kenny as its first Chief Executive Officer

Sun Pharma to acquire Organon in US$ 11.75 billion deal

Zócalo Health secures $15 million in funding to expand care for Latino communities

GE HealthCare expands partnership to bring AI breast cancer screening to global markets

Donors pledge USD 800 million to tackle maternal and child mortality

ScreenPoint Medical secures 13.6 million euros to advance breast cancer AI technology

Women to have greater say in care under renewed health strategy

Eka Ventures becomes UK’s largest early-stage impact VC with $107 million fund close